patent cliff

The Top Line
Podcast

A closer look at pharma’s top patent losses in 2025

This week on "The Top Line," we explore the potential impacts of this year's sizable patent cliff on the pharma industry at large.
Merck Co

Merck touts newly approved Winrevair as example of BD acumen

Apr 25, 2024 11:06am
Anderson

Bayer CEO tables split-up, begins 'full-scale effort' for pharma

Mar 5, 2024 10:17am
Boerner

BMS CEO outlines transition strategy featuring 11 brands, BD

Feb 2, 2024 11:30am
MA

Patent cliffs and divestitures point to an uptick in M&A

Sep 7, 2023 3:22pm
Takeda

Amid shortage, FDA clears several generics of Takeda's Vyvanse

Aug 30, 2023 2:27pm